547 related articles for article (PubMed ID: 23088810)
21. Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9.
Chung AW; Rauniyar P; Luo H; Hsiang YN; van Breemen C; Okon EB
J Vasc Surg; 2005 Oct; 42(4):747-56. PubMed ID: 16242564
[TBL] [Abstract][Full Text] [Related]
22. The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent.
Guo J; Breen DM; Pereira TJ; Dalvi PS; Zhang H; Mori Y; Ghanim H; Tumiati L; Fantus IG; Bendeck MP; Dandona P; Rao V; Dolinsky VW; Heximer SP; Giacca A
Atherosclerosis; 2015 Jul; 241(1):111-20. PubMed ID: 25974101
[TBL] [Abstract][Full Text] [Related]
23. Estrogen effects on MMP-13 and MMP-14 regulation of left ventricular mass in Dahl salt-induced hypertension.
Dai Q; Lin J; Craig T; Chou YM; Hinojosa-Laborde C; Lindsey ML
Gend Med; 2008 Mar; 5(1):74-85. PubMed ID: 18420168
[TBL] [Abstract][Full Text] [Related]
24. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L
J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975
[TBL] [Abstract][Full Text] [Related]
25. [Effects of tissue inhibitor of matrix metalloproteinases-4 on the activities of matrix metalloproteinases and collagen of artery: experiment with rats].
Zu LY; Guo YH; Chen L; Li Q; Yan H; Gao W
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):472-5. PubMed ID: 16677575
[TBL] [Abstract][Full Text] [Related]
26. [Inulicin inhibits activation and expression of vascular remodeling enzymes induced by de-endothelium].
Li JJ; Wen JK; Han M
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 May; 24(2):156-60. PubMed ID: 21141515
[TBL] [Abstract][Full Text] [Related]
27. Intraluminal Delivery of Simvastatin Attenuates Intimal Hyperplasia After Arterial Injury.
Helkin A; Bruch D; Wilson DR; Gruessner AC; Bader RR; Maier KG; Gahtan V
Vasc Endovascular Surg; 2019 Jul; 53(5):379-386. PubMed ID: 30982448
[TBL] [Abstract][Full Text] [Related]
28. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.
Wang L; Zheng J; Bai X; Liu B; Liu CJ; Xu Q; Zhu Y; Wang N; Kong W; Wang X
Circ Res; 2009 Mar; 104(5):688-98. PubMed ID: 19168437
[TBL] [Abstract][Full Text] [Related]
29. Estrogen deficiency-induced alterations of vascular MMP-2, MT1-MMP, and TIMP-2 in ovariectomized rats.
Lam KK; Cheng PY; Hsiao G; Chen SY; Shen HH; Yen MH; Lee YM
Am J Hypertens; 2009 Jan; 22(1):27-34. PubMed ID: 19023275
[TBL] [Abstract][Full Text] [Related]
30. 20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries.
Orozco LD; Liu H; Perkins E; Johnson DA; Chen BB; Fan F; Baker RC; Roman RJ
J Pharmacol Exp Ther; 2013 Jul; 346(1):67-74. PubMed ID: 23658377
[TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproteinase (MMP)-2, MMP-14 and tissue inhibitor of matrix metalloproteinase (TIMP)-2 during bovine placentation and at term with or without placental retention.
Dilly M; Hambruch N; Shenavai S; Schuler G; Froehlich R; Haeger JD; Ozalp GR; Pfarrer C
Theriogenology; 2011 Apr; 75(6):1104-14. PubMed ID: 21247626
[TBL] [Abstract][Full Text] [Related]
32. MT1-MMP evaluation in neointimal hyperplasia in the late follow-up after prosthesis implantation.
Bruczko M; Gogiel T; Wolańska M; Kowalewski R; Sobolewski K; Romanowicz L
Int J Exp Pathol; 2019 Apr; 100(2):94-101. PubMed ID: 31058412
[TBL] [Abstract][Full Text] [Related]
33. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
[TBL] [Abstract][Full Text] [Related]
34. Cordycepin inhibits vascular smooth muscle cell proliferation.
Chang W; Lim S; Song H; Song BW; Kim HJ; Cha MJ; Sung JM; Kim TW; Hwang KC
Eur J Pharmacol; 2008 Nov; 597(1-3):64-9. PubMed ID: 18782572
[TBL] [Abstract][Full Text] [Related]
35. Effects of hormone replacement therapy type and route of administration on plasma matrix metalloproteinases and their tissue inhibitors in postmenopausal women.
Lewandowski KC; Komorowski J; Mikhalidis DP; Bienkiewicz M; Tan BK; O'Callaghan CJ; Lewinski A; Prelevic G; Randeva HS
J Clin Endocrinol Metab; 2006 Aug; 91(8):3123-30. PubMed ID: 16705077
[TBL] [Abstract][Full Text] [Related]
36. [Role of cytokine-matrix metalloproteinase axis on promoting vascular neointima hyperplasia in mice].
Liu Y; Ning WH; Shen XH; Guo DL; Guo L
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):961-967. PubMed ID: 27903395
[No Abstract] [Full Text] [Related]
37. The effects of estrogen and androgen on tear secretion and matrix metalloproteinase-2 expression in lacrimal glands of ovariectomized rats.
Song X; Zhao P; Wang G; Zhao X
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):745-51. PubMed ID: 24334444
[TBL] [Abstract][Full Text] [Related]
38. Ovariectomy in aged versus young rats augments matrix metalloproteinase-mediated vasoconstriction in mesenteric arteries.
Lekontseva ON; Rueda-Clausen CF; Morton JS; Davidge ST
Menopause; 2010; 17(3):516-23. PubMed ID: 20142791
[TBL] [Abstract][Full Text] [Related]
39. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury.
Shofuda K; Nagashima Y; Kawahara K; Yasumitsu H; Miki K; Miyazaki K
Lab Invest; 1998 Aug; 78(8):915-23. PubMed ID: 9714179
[TBL] [Abstract][Full Text] [Related]
40. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
Kranzhöfer A; Baker AH; George SJ; Newby AC
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
